Search

Showing "11155" results for ""

Lopinavir/ritonavir cost-effective first-line after single-dose nevirapine in South Africa

Once-daily Kaletra as safe and effective as twice-daily dosing

English government considering revising policy on charging foreign nationals for HIV treatment

`Test and treat` unlikely to halt Washington epidemic

Cost of ART delivery in Malawi affordable within WHO-recommended health budget

Antiretroviral roll-out results in major TB decline in South African study

Boosted and unboosted atazanavir maintain viral suppression equally well

Boosted darunavir monotherapy works well in two studies

Aciclovir reduces disease progression and death in people with HIV by nearly 20 per cent

Early tests of maraviroc as microbicide produce less activity than expected

Anal cancer in men with HIV much more common in post-HAART era: could HPV vaccination help?

Sustained response to interferon improves fibrosis in HIV/HCV co-infected patients

Delays in starting treatment common in ART programmes

Antiretrovirals and condoms will have more effect on HIV in South Africa than circumcision, model finds

ART for mothers leading to decline in child deaths, KwaZulu Natal study finds

Male partner clinic attendance and HIV testing associated with better outcomes for infants born to HIV-positive mothers

BAN study: Giving ART to mothers or ARV prophylaxis to infants during breastfeeding equally effective at reducing HIV transmission

Nurse management of ART matches doctor care in South African trial

Receive the latest HIV research and conference news

Showing "11155" results for ""

Lopinavir/ritonavir cost-effective first-line after single-dose nevirapine in South Africa

Once-daily Kaletra as safe and effective as twice-daily dosing

English government considering revising policy on charging foreign nationals for HIV treatment

`Test and treat` unlikely to halt Washington epidemic

Cost of ART delivery in Malawi affordable within WHO-recommended health budget

Antiretroviral roll-out results in major TB decline in South African study

Boosted and unboosted atazanavir maintain viral suppression equally well

Boosted darunavir monotherapy works well in two studies

Aciclovir reduces disease progression and death in people with HIV by nearly 20 per cent

Early tests of maraviroc as microbicide produce less activity than expected

Anal cancer in men with HIV much more common in post-HAART era: could HPV vaccination help?

Sustained response to interferon improves fibrosis in HIV/HCV co-infected patients

Delays in starting treatment common in ART programmes

Antiretrovirals and condoms will have more effect on HIV in South Africa than circumcision, model finds

ART for mothers leading to decline in child deaths, KwaZulu Natal study finds

Male partner clinic attendance and HIV testing associated with better outcomes for infants born to HIV-positive mothers

BAN study: Giving ART to mothers or ARV prophylaxis to infants during breastfeeding equally effective at reducing HIV transmission

Nurse management of ART matches doctor care in South African trial

Receive the latest HIV research and conference news